Yar Saglam, Atiye Seda, et al. “HDAC Inhibitors, MS-275 and Salermide, Potentiates the Anticancer Effect of EF24 in Human Pancreatic Cancer Cells”. EXCLI Journal, vol. 15, Apr. 2016, pp. 246-55, doi:10.17179/excli2016-186.